Cases 41 - 50 of 106
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2019cv02317
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings Limited and others
Defendant:
Sun Pharmaceutical Industries Limited, Cadila Healthcare Limited, Aurobindo Pharma USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc.
as 1:2019cv02197
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Aurobindo Pharma USA Inc.
as 1:2019cv02113
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01965
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01862
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01674
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
